Literature DB >> 3420932

Prognostic value of nuclear DNA content in papillary and follicular thyroid cancer.

J F Hamming, L J Schelfhout, C J Cornelisse, C J van de Velde, B M Goslings, J Hermans, G J Fleuren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3420932     DOI： 10.1007/BF01655433

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  23 in total

1.  Statistical evaluation of the prognostic value of nuclear DNA content in papillary, follicular, and medullary thyroid tumors.

Authors:  M Bäckdahl; J Carstensen; G Auer; E Tallroth
Journal:  World J Surg       Date:  1986-12       Impact factor: 3.352

2.  Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis.

Authors:  H S Goh; J R Jass; W S Atkin; J Cuzick; J M Northover
Journal:  Int J Colorectal Dis       Date:  1987-02       Impact factor: 2.571

3.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.

Authors:  D P Byar; S B Green; P Dor; E D Williams; J Colon; H A van Gilse; M Mayer; R J Sylvester; M van Glabbeke
Journal:  Eur J Cancer       Date:  1979-08       Impact factor: 9.162

4.  Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.

Authors:  D W Hedley; M L Friedlander; I W Taylor
Journal:  Cytometry       Date:  1985-07

5.  Tumor DNA content in primary and metastatic colorectal carcinoma.

Authors:  W A Kokal; R B Duda; N Azumi; K Sheibani; M M Kemeny; J J Terz; J R Harada
Journal:  Arch Surg       Date:  1986-12

6.  Risk factor analysis in differentiated thyroid cancer.

Authors:  B Cady; C E Sedgwick; W A Meissner; M S Wool; F A Salzman; J Werber
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

7.  Prognosis in thyroid carcinoma.

Authors:  K O Franssila
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

8.  Flow cytometry as a tool for the prognostic assessment of human neoplasia.

Authors:  F Mauro; L Teodori; J Schumann; W Göhde
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-04       Impact factor: 7.038

9.  Multifactorial study of prognostic factors in differentiated thyroid carcinoma and a re-evaluation of the importance of age.

Authors:  F Bacourt; B Asselain; J C Savoie; E D'Hubert; J P Massin; G Doucet; A Leger; H Garnier
Journal:  Br J Surg       Date:  1986-04       Impact factor: 6.939

10.  Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer?

Authors:  P J Finan; P Quirke; M F Dixon; J E Dyson; G R Giles; C C Bird
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640
View more
  10 in total

1.  Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy.

Authors:  D C Allison; K K Bose; R H Hruban; S Piantadosi; W C Dooley; J K Boitnott; J L Cameron
Journal:  Ann Surg       Date:  1991-12       Impact factor: 12.969

2.  Nuclear DNA content of medullary thyroid carcinoma in a large family with the MEN-2A syndrome.

Authors:  H R Haak; C J Cornelisse; B M Goslings; G J Fleuren
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

3.  Prognostic significance of DNA content abnormalities in young patients with colorectal cancer.

Authors:  T M Heimann; G Martinelli; A Szporn; R J Kurtz; A Quish; F Miller; S C Oh; T Fasy
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

4.  Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors.

Authors:  C S Grant; I D Hay; J J Ryan; E J Bergstralh; L M Rainwater; J R Goellner
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

Review 5.  The clinician and the thyroid.

Authors:  H J Biersack; A Hotze
Journal:  Eur J Nucl Med       Date:  1991

6.  Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?

Authors:  C A Proye; D H Dromer; B M Carnaille; A J Gontier; A Goropoulos; P Carpentier; J Lefebvre; M Decoulx; J L Wemeau; P Fossati
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

7.  Nuclear DNA analysis and prognosis in carcinoma of the thyroid gland. A nationwide study in Iceland on carcinomas diagnosed 1955-1990.

Authors:  J G Jónasson; J Hrafnkelsson
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Hürthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior.

Authors:  M F Herrera; I D Hay; P S Wu; J R Goellner; J J Ryan; J R Ebersold; E J Bergstralh; C S Grant
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

9.  Follicular tumors of the thyroid gland: diagnosis, clinical aspects and nuclear DNA analysis.

Authors:  J Zedenius; G Auer; M Bäckdahl; U Falkmer; L Grimelius; G Lundell; G Wallin
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

Review 10.  Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.

Authors:  A P Zbar; N R Lemoine; M Wadhwa; H Thomas; D Snary; W A Kmiot
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.